suboxone
Indivior shares fall by 70% after allegations of fraud
April 10, 2019Research and Development Virginia, indivior, opioid crisis, opioids, suboxone
Shares in London-listed Indivior plummeted this morning after US Federal prosecutors said the British drugmaker had deceived doctors as to …
Dr Reddy’s just-approved opioid dependence generic blocked over US patent dispute
June 18, 2018Sales and Marketing Dr Reddy's, FDA, Mylan, US, opioid crisis, opioid dependence, opioids, suboxone
Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) …
Indivior reaches settlement with Mylan over patent dispute
September 25, 2017Sales and Marketing Mylan, indivior, patent, pharma, pharmaceutical, suboxone
Indivior has ended a patent dispute with Mylan concerning its heroin addiction therapy Suboxone (buprenorphine and naloxone) sublingual film by …
Reckitt finalises pharmaceutical demerger plans
November 19, 2014Business Services, Sales and Marketing Reckitt Benckiser Pharmaceuticals, cillit bang, indivior, suboxone
Reckitt Benckiser has confirmed its plans to spin-off its pharmaceutical portfolio from its core consumer products business. Final details of …
Reckitt Benckiser may shed pharma unit
October 23, 2013Sales and Marketing Reckitt Benckiser Pharmaceuticals, rbp, suboxone
Reckitt Benckiser Pharmaceuticals is considering selling its pharma unit within the next year after the recent loss of its biggest …
